Companies
- Companies
- Browse
Companies
Is committed to building on success, and the continued in-licensing of products and technologies is an acknowledged strategic priority More
BTG is an international specialty pharmaceuticals company that is developing and commercialising products targeting critical care, cancer, neurological and other disorders. More
Isis Innovation is a wholly owned subsidiary of the University of Oxford, founded to exploit know-how arising out of research at one of the World's premier research institutions More
Scil Biomedicals business objective is to develop and market innovative, protein-based biopharmaceuticals and medical devices. More
CrystalGenomics is a structure based drug discovery company, generating novel small molecular therapeutics such as antibiotics, anti-cancer and quality of life improving drugs. More
Related Reports
Market Research Reports provided by reports.iptechex.com
Nov 2010 - 40 pages - $500
Mar 2011 - 82 pages - $500
Oct 2011 - 134 pages - $500
Dec 2010 - 84 pages - $500
Apr 2009 - 450 pages - $3,490
Mar 2011 - 34 pages - $1,000
Jun 2006 - 378 pages - $2,495
Jan 2011 - 99 pages - $3,835
Aug 2010 - 80 pages - $1,215
Sep 2010 - 21 pages - $99
Your selection
Browse By
- Industry sector
- Bioinformatics
- Combinatorial biology
- Combinatorial chemistry
- Drug research platforms
- Genomics
- High throughput screening
- Proteomics
- Therapeutic target
- Arthritis (non-specific)
- Bone fractures
- Bone repair/regeneration
- Osteoarthritis
- Osteopetrosis
- Osteoporosis
- Paget's disease
- Rheumatic disorders (other)
- Rheumatoid arthritis
- Geographic location
- Africa
- Asia
- Australia/New Zealand
- Central America
- Europe
- Near & Far East
- North America
- South America
© Copyright 1998-2013 IP Technology Exchange, Inc All rights reserved. Terms and Conditions | Contact us